[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis].

Gregory P Arutyunov G P Arutiunov Alexander G Arutyunov Y N Belenkov Alexandra Olegovna Konradi Y M Lopatin Andrey P Rebrov Sergey Tereshchenko A I Chesnikova H G HayrapetyanA P BabinIgor Bakulin Natalia Bakulina Larisa A Balykova A S Blagonravova M V Boldina A R Vaisberg A S Galyavich V V Gomonova N Y Grigorieva I V Gubareva I V DemkoA V EvzerikhinaA V Zharkov U K Kamilova Z F Kim Tatjana Yurjevna Kuznetsova N V Lareva Ekaterina V Makarova S V Malchikova S M Nedogoda Marina M Petrova I G Pochinka K V Protasov Denis N Protsenko D I Ruzanov S A Sayganov Akpay Sarybaev N M Selezneva A B Sugraliev I V Fomin O V Khlynova O Y Chizhova Igor ShaposhnikD A Sh'ukarevА K AbdrahmanovaS A AvetisianH G AvoyanK K AzarianG T AimakhanovaD A AyipovaA C AkunovM K Alieva A V Aparkina O R Aruslanova E Y Ashina O Y Badina O Y BarishevaA S BatchayevaA M Bitieva I U Bikhteyev N A Borodulina M V BraginA M BuduG M BykovaK R VagapovaD D Varlamova N N Vezikova E A Verbitskaya O E Vilkova E A Vinnikova V V Vustina E A Galova Vadim V GenkelE I GorsheninaR V Gostishev E V Grigorieva E Y GubarevaG M DabylovaA I DemchenkoO Y DolgikhM Y DuyshobayevD S Evdokimov K E Egorova A N ErmilovaA E ZheldybayevaN V ZarechnovaY D Zimina S Y Ivanova E Y Ivanchenko M V Ilina M V KazakovtsevaE V KazymovaY S KalininaN A KamardinaA M Karachenova I A Karetnikov N A Karoli M K Karsiev D S Кaskaeva K F KasymovaZ B KerimbekovaA S KerimovaE S KimN V KiselevaD A KlimenkoA V Klimova O V KovalishenaE V KolmakovaT P KolchinskayaM I Kolyadich O V Kondriakova M P Konoval D Y Konstantinov E A KonstantinovaV A KordukovaE V KorolevaA Y KraposhinaT V KriukovaAlla Kuznetsova T Y KuzminaK V KuzmichevC K KulchoroevnaT V KuprinaI M KouranovaL V KurenkovaN Y Kurchugina Nadira Kushubakova V I Levankova N A Lyubavina N A MagdeyevaK V MazalovV I Majseenko A S Makarova A M Maripov A A Marusina E S Melnikov N B Moiseenko F N MuradovaR G MuradyanS N MusaelianA O MyshakE S Nekaeva N M NikitinaB B OgurlievaA A Odegova Y V Omarova Nazgul OmurzakovaS O OspanovaE V PahomovaL D PetrovS S PlastininaV A PogrebetskayaD S PolyakovE V PonomarenkoL L Popova N A ProkofevaI A PudovaN A RakovA N RahimovN A RozanovaS SerikbolkyzyA A Simonov V V Skachkova D V Soloveva I A SolovevaA K SubbotinI M SukhomlinovaA G SushilovaD R TagayevaY V Titojkina E P TihonovaD S TokminA A Tolmacheva M S Torgunakova K V TrenoginaN A TrostianetckaiaD A Trofimov A A TulichevA T TursunovaN D Ulanova O V Fatenkov O V FedorishinaT S FilI Y FominaI S FominovaI A FrolovaS M Tsvinger V V TsomaM B CholponbaevaT I ChudinovskikhO A ShevchenkoT V SheshinaE A Shishkina K Y ShishkovS Y SherbakovE A Yausheva

Published in: Terapevticheskii arkhiv (2022)

Polymorbidity determined by way of simple counting of diseases may be estimated as a factor in the lethal outcome risk in the acute phase of COVID-19 in real practice. Most frequent combinations of 2, 3 and 4 diseases in patients with COVID-19 primarily include cardiovascular diseases (AH, CHD and CHF), diabetes mellitus and obesity. Combinations of such diseases increase the COVID-19 lethal outcome risk.

Keyphrases